Default: Journal for ImmunoTherapy of Cancer

ISSN:

Journal Home

Journal Guideline

Journal for ImmunoTherapy of Cancer Q1 Unclaimed

BioMed Central Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal for ImmunoTherapy of Cancer is a journal indexed in SJR in Pharmacology and Molecular Medicine with an H index of 45. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1694 €. The scope of the journal is focused on tumour immunology, cancer immunotherapy, immunotherapy biomarkers. It has an SJR impact factor of 4,194 and it has a best quartile of Q1. It is published in Western Europe.

Type: Journal

Type of Copyright: CC BY

Languages: Western Europe

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Metrics

Journal for ImmunoTherapy of Cancer

4,194

SJR Impact factor

45

H Index

357

Total Docs (Last Year)

350

Total Docs (3 years)

14235

Total Refs

3038

Total Cites (3 years)

311

Citable Docs (3 years)

9,8

Cites/Doc (2 years)

39,87

Ref/Doc

Aims and Scope


Tumour immunology Cancer immunotherapy Immunotherapy biomarkers

Comments

No comments ... Be the first to comment!